The impact of the improvement of glycometabolism in patients with type 2 diabetes on sleep disturbance including sleep disordered breathing following an admission to control their glucose metabolism.
Not Applicable
- Conditions
- type 2 diabetes with sleep disturbance including sleep disordered breathing
- Registration Number
- JPRN-UMIN000045728
- Lead Sponsor
- ihon University of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 80
Inclusion Criteria
Not provided
Exclusion Criteria
1.Patients who were already diagnosed as sleep apnea syndrome and treated. 2.Patients with diabetes who were diagnosed as not tyoe 2 but the others. 3.Patients with diabetic ketosis or ketoacidosis 4.Patients with cancer 5.Patients taking corticosteroids. 6.Patients on oxygen therapy 7.Patients with hemodialysis 8.Patients with a cardiac pacemaker 9.Premenoposal female 10. Patients with physical activity restrictions due to disability 11.Patients who refuse to participate in this trial. 12. Patients who are judged to be inappropriate as a candidate by the doctor.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Changes in the severity of sleep disturbance such as respiratory event index, objective sleep duration, the severity of sleep disruption, and sleep latency)
- Secondary Outcome Measures
Name Time Method Blood sugar level HOMA-IR HOMA-beta BMI Lipid metabolism ABI(Ankle - Brachial Index) PWV(PulseWave Velocity) Intima Media Thickness